Epidemiology 29 , e45e47 (2018)
Compounded versions typically come in a small, sterile glass vial, and you use a tiny syringe to draw up the dose yourself
NAD+ may be a better option if you experience fatigue and low energy, are concerned about aging, are recovering from DNA damage or if you want to support your overall cognitive health and metabolic function
As in the LEAN study, the primary outcome is histologic resolution of NASH without worsening of fibrosis after 72 weeks of treatment, while secondary outcomes include improvement in liver fibrosis (1 stage) with no worsening of NASH, NAFLD activity score, as well as multiple serum markers of fibrosis
Specifically: Whether 2.5 mg per week sustains weight loss as effectively as 5 mg over 72 weeks remains unstudied Whether weight regain happens faster at lower maintenance doses if treatment is paused remains unknown Whether the cardiovascular and metabolic benefits seen at 5 mg and above apply at lower doses has not been tested Whether longer titration schedules produce different long-term outcomes than the standard 4-weeks-per-step regimen has limited data The body of evidence underpinning tirzepatide's approval is built on the 5/10/15 mg structure with a 2.5 mg starter step